Skip to main content
. 2021 Dec 30;7(1):1082–1089. doi: 10.1021/acsomega.1c05671

Scheme 1. Reagents and Conditions: (a) 4-Nitrophenyl Chloroformate, Pyridine, DCM, rt; (b) Exatecan, DMAP, DMF, rt; (c) N3PEG4NHBoc, Cu(MeCN)4PF6, DCM, rt; (d) TFA, DCM, rt; and (e) EMCS, DIPEA, DCM, rt.

Scheme 1